Abstract:PURPOSE: Matrix metalloproteinase (MMP)-2 and MMP-9 are considered to play an important role in the metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) and tissue inhibitor of metalloproteinase 2 (TIMP-2) are essential factors for the activation of pro-MMP-2. There are some reports about expressions of MMP family in relationship to clinical features of head and neck squamous cell carcinoma (SCC), but the results were not uniform and the prognostic value of their expressions remains unclear.EXPERIMENTAL DESIGN: The study group consisted of 53 Japanese patients with oral SCC of early stage (T(1-2)N(0)M(0)). Expressions of MMP-2, MMP-9, MT1-MMP, and TIMP-2 were examined using immunohistological methods on the sections of tumor biopsy samples. The intensity of MMP expression was categorized into four grades (score 0-3) by semiquantitative analysis using a computer with NIH image, and correlation between this grade and clinical aspects such as tumor recurrence, metastasis, and prognosis were examined.RESULTS: The expression score of MMP-2 correlated with that of MMP-9 (r = 0.291; P = 0.036), MT1-MMP (r = 0.286; P = 0.039), and TIMP-2 (r = 0.257; P = 0.050). Patients who developed regional lymph node and/or distant metastasis showed significantly higher scores in the expressions of MMP-9 and TIMP-2 than patients without any tumor metastases (P = 0.036 and P = 0.043, respectively). Kaplan-Meier analyses as well as univariate analyses using the Cox proportional hazards model showed that expression of MMP-9 (P = 0.0143 and P = 0.0418, respectively) and marked expression of TIMP-2 (P < 0.0001 and P = 0.0004, respectively) correlated with worse-cause-specific survival. Multivariate analysis confirmed that marked expression of TIMP-2 was the only independent factor for cause-specific death (hazard ratio, 7.543; confidence interval, 1.693-33.610; P = 0.0080).CONCLUSIONS: Expressions of MMP-9 and TIMP-2 have predictive value for tumor metastases and cause-specific survival. High expression of TIMP-2 is the most independent factor for worse prognosis in early-stage oral SCC.

Expression and Significance of Matrix Metalloproteinases in Carcinogenesis of Oral Mucosa

Expression of MMP-2 and MMP-9 and FHIT in Oral Squamous Cell Carcinoma

COX-2, MMP-7 Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma

The Role of Matrix Metalloproteinases and Their Tissue Inhibitors in Oral Lichen Planus

Immunoexpression of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Metastasis of Squamous Cell Carcinoma of the Human Tongue

Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

Expression of MMP-1,MMP-2,uPA in oral squamous cell carcinoma

Expression and Significance of E-cd and MMP-2 in Oral Squamous Cell Carcinoma

Clinical Significance Of Ngal And Mmp-9 Protein Expression In Epithelial Ovarian Cancers

Expression and Significance of MMP-2 and TIMP-2 in Human Colorectal Carcinoma and Its Metastasis

Mmps, Timp-2, And Tgf-Beta 1 In The Cancerization Of Oral Lichen Planus

Expression of MMP-9 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma

The expression of matrix metalloproteinase-9 in oral verrucous carcinoma

The expression and significance of MMP-9 in cervical cancer

Expressions of Matrix Metalloproteinase-2 and -9 in Pancreatic Carcinoma and Its Significance

[The Expression of Matrix Metalloproteinase-2 and -9 in Cervical Cancer and a Study of Their Relationship].

Expression and Significance of MMP-2 and TIMP-2 in Colorectal Carcinoma

Relationship between expression of MMP-2 and cervical lymph node micrometastasis in oral squamous cell carcinoma

Expressions of Matrix Metalloproteinase 2 and Carbohydrate Antigen 50 in Colorectal Carcinoma,Transitional Mucosa and Normal Colorectal Mucosa and Its Clinical Significance

The Expression of MDM2 and p53 in Oral Squamous Cell Carcinoma and Oral Leukoplakia

[Expression and Clinical Significance of Matrix Metalloproteinase-2 in Laryngeal Squamous Cell Carcinoma].